“Dapagliflozin and Sitagliptin Combination Therapy: An Overview of Clinical Utility in Type 2 Diabetes Mellitus with Multiple Cardiovascular Risk Factors”, ccm, vol. 7, no. 2, pp. 141–144, Apr. 2023, Accessed: Sep. 17, 2026. Available: https://fortunejournals.org/ojs/index.php/ccm/article/view/16403